Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine A Janeway

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Nature Cancer|April 24, 2024
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trialMeenakshi Hegde, Shoba Navai, Christopher DeRenzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2023
The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric CancerJoseph A Flores-Toro, Subhashini Jagu, Gregory T Armstrong, et al.
Nature Communications|June 23, 2016
Integrated genetic and pharmacologic interrogation of rare cancersAndrew L Hong, Yuen-Yi Tseng, Glenn S Cowley, et al.
Nature Communications|July 11, 2024
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancerSuzanne J Forrest, Hersh Gupta, Abigail Ward, et al.
Neuro-Oncology|January 21, 2017
Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumorsShakti H Ramkissoon, Pratiti Bandopadhayay, Jaeho Hwang, et al.
Journal of the National Cancer Institute|September 25, 2025
SMARCAL1 is a new osteosarcoma predisposition geneMaryam Rafati, Lillian M Guenther, Laura E Egolf, et al.
Elife|March 13, 2019
Renal medullary carcinomas depend upon <i>SMARCB1</i> loss and are sensitive to proteasome inhibitionAndrew L Hong, Yuen-Yi Tseng, Jeremiah A Wala, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
Genome-wide association study meta-analysis identifies susceptibility loci informing Ewing sarcoma etiology and potential mechanisms of riskAubrey K Hubbard, Hélène Neyret-Kahn, Martina Müller-Nurasiyd, et al.
JCI Insight|November 25, 2016
Institutional implementation of clinical tumor profiling on an unselected cancer populationLynette M Sholl, Khanh Do, Priyanka Shivdasani, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcomaJennifer A Perry, Adam Kiezun, Peter Tonzi, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Nature Cancer|April 24, 2024
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trialMeenakshi Hegde, Shoba Navai, Christopher DeRenzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2023
The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric CancerJoseph A Flores-Toro, Subhashini Jagu, Gregory T Armstrong, et al.
Nature Communications|June 23, 2016
Integrated genetic and pharmacologic interrogation of rare cancersAndrew L Hong, Yuen-Yi Tseng, Glenn S Cowley, et al.
Nature Communications|July 11, 2024
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancerSuzanne J Forrest, Hersh Gupta, Abigail Ward, et al.
Neuro-Oncology|January 21, 2017
Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumorsShakti H Ramkissoon, Pratiti Bandopadhayay, Jaeho Hwang, et al.
Journal of the National Cancer Institute|September 25, 2025
SMARCAL1 is a new osteosarcoma predisposition geneMaryam Rafati, Lillian M Guenther, Laura E Egolf, et al.
Elife|March 13, 2019
Renal medullary carcinomas depend upon <i>SMARCB1</i> loss and are sensitive to proteasome inhibitionAndrew L Hong, Yuen-Yi Tseng, Jeremiah A Wala, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
Genome-wide association study meta-analysis identifies susceptibility loci informing Ewing sarcoma etiology and potential mechanisms of riskAubrey K Hubbard, Hélène Neyret-Kahn, Martina Müller-Nurasiyd, et al.
JCI Insight|November 25, 2016
Institutional implementation of clinical tumor profiling on an unselected cancer populationLynette M Sholl, Khanh Do, Priyanka Shivdasani, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcomaJennifer A Perry, Adam Kiezun, Peter Tonzi, et al.
Pageof 15